Production (Stage)
IRadimed Corporation
IRMD
$57.88
-$0.26-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.78M | 19.23M | 18.63M | 18.64M | 17.92M |
| Total Depreciation and Amortization | 785.70K | 817.70K | 828.20K | 820.50K | 808.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.76M | 1.82M | 1.91M | 1.69M | 2.08M |
| Change in Net Operating Assets | 3.70M | 3.75M | 2.19M | -5.32M | -8.11M |
| Cash from Operations | 26.03M | 25.62M | 23.55M | 15.83M | 12.70M |
| Capital Expenditure | -11.43M | -8.01M | -5.75M | -2.24M | -1.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -823.40K | -811.80K | -646.10K | -575.50K | -613.70K |
| Cash from Investing | -12.26M | -8.82M | -6.39M | -2.82M | -1.93M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 29.60K | 29.60K | 172.70K | 172.70K | 176.70K |
| Repurchase of Common Stock | -740.50K | -688.10K | -577.60K | -591.20K | -624.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.86M | -13.68M | -11.78M | -9.88M | -7.98M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.57M | -14.34M | -12.18M | -10.29M | -8.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 5.20M | 2.47M | 4.98M | 2.71M | 2.35M |